US Stock MarketDetailed Quotes

PLX Protalix Biotherapeutics

Watchlist
  • 2.545
  • -0.035-1.36%
Trading Mar 31 13:54 ET
198.59MMarket Cap63.63P/E (TTM)

Protalix Biotherapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Feb 3, 2025

Based on 1 analysts giving stock ratings to Protalix Biotherapeutics in the past 3 months

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

Updated: Feb 3, 2025

The average Protalix Biotherapeutics stock price target is 15.00 with a max estimate of 15.00 and a min estimate of 15.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Market Insights

Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More